Logo image of YTSN.DE

KUROS BIOSCIENCES AG-REG (YTSN.DE) Stock Fundamental Analysis

FRA:YTSN - Deutsche Boerse Ag - CH0325814116 - Common Stock - Currency: EUR

31.04  +1.24 (+4.16%)

Fundamental Rating

4

Taking everything into account, YTSN scores 4 out of 10 in our fundamental rating. YTSN was compared to 67 industry peers in the Biotechnology industry. YTSN has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, YTSN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year YTSN has reported negative net income.
In the past year YTSN had a positive cash flow from operations.
YTSN had negative earnings in each of the past 5 years.
In the past 5 years YTSN reported 4 times negative operating cash flow.
YTSN.DE Yearly Net Income VS EBIT VS OCF VS FCFYTSN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

With a decent Return On Assets value of -5.07%, YTSN is doing good in the industry, outperforming 67.16% of the companies in the same industry.
YTSN has a Return On Equity of -7.30%. This is in the better half of the industry: YTSN outperforms 70.15% of its industry peers.
Industry RankSector Rank
ROA -5.07%
ROE -7.3%
ROIC N/A
ROA(3y)-13.96%
ROA(5y)-12.47%
ROE(3y)-17.57%
ROE(5y)-15.22%
ROIC(3y)N/A
ROIC(5y)N/A
YTSN.DE Yearly ROA, ROE, ROICYTSN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

The Gross Margin of YTSN (82.10%) is better than 76.12% of its industry peers.
YTSN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for YTSN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.84%
GM growth 5Y1.82%
YTSN.DE Yearly Profit, Operating, Gross MarginsYTSN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

7

2. Health

2.1 Basic Checks

YTSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, YTSN has more shares outstanding
YTSN has more shares outstanding than it did 5 years ago.
YTSN has a better debt/assets ratio than last year.
YTSN.DE Yearly Shares OutstandingYTSN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
YTSN.DE Yearly Total Debt VS Total AssetsYTSN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

YTSN has an Altman-Z score of 28.47. This indicates that YTSN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 28.47, YTSN belongs to the best of the industry, outperforming 97.01% of the companies in the same industry.
YTSN has a debt to FCF ratio of 2.44. This is a good value and a sign of high solvency as YTSN would need 2.44 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.44, YTSN belongs to the top of the industry, outperforming 92.54% of the companies in the same industry.
YTSN has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
YTSN has a Debt to Equity ratio of 0.08. This is in the better half of the industry: YTSN outperforms 71.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 2.44
Altman-Z 28.47
ROIC/WACCN/A
WACC5.02%
YTSN.DE Yearly LT Debt VS Equity VS FCFYTSN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.14 indicates that YTSN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.14, YTSN is in line with its industry, outperforming 55.22% of the companies in the same industry.
A Quick Ratio of 1.69 indicates that YTSN should not have too much problems paying its short term obligations.
The Quick ratio of YTSN (1.69) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.69
YTSN.DE Yearly Current Assets VS Current LiabilitesYTSN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

YTSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.49%, which is quite impressive.
YTSN shows a strong growth in Revenue. In the last year, the Revenue has grown by 142.50%.
YTSN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 105.10% yearly.
EPS 1Y (TTM)69.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.07%
Revenue 1Y (TTM)142.5%
Revenue growth 3Y88.78%
Revenue growth 5Y105.1%
Sales Q2Q%111.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
YTSN.DE Yearly Revenue VS EstimatesYTSN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

YTSN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
YTSN.DE Price Earnings VS Forward Price EarningsYTSN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, YTSN is valued cheaper than 80.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF 562.18
EV/EBITDA N/A
YTSN.DE Per share dataYTSN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

YTSN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KUROS BIOSCIENCES AG-REG

FRA:YTSN (7/25/2025, 7:00:00 PM)

31.04

+1.24 (+4.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-17 2025-04-17
Earnings (Next)08-13 2025-08-13
Inst Owners14.84%
Inst Owner ChangeN/A
Ins Owners1.9%
Ins Owner ChangeN/A
Market Cap1.20B
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.09
P/FCF 562.18
P/OCF 363.09
P/B 19.41
P/tB 46.87
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY0.18%
OCF(TTM)0.09
OCFY0.28%
SpS2.06
BVpS1.6
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.07%
ROE -7.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.1%
FCFM 2.68%
ROA(3y)-13.96%
ROA(5y)-12.47%
ROE(3y)-17.57%
ROE(5y)-15.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.84%
GM growth 5Y1.82%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 2.44
Debt/EBITDA N/A
Cap/Depr 42.18%
Cap/Sales 1.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.69
Altman-Z 28.47
F-Score6
WACC5.02%
ROIC/WACCN/A
Cap/Depr(3y)22.71%
Cap/Depr(5y)17.87%
Cap/Sales(3y)1.56%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)142.5%
Revenue growth 3Y88.78%
Revenue growth 5Y105.1%
Sales Q2Q%111.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y135.5%
OCF growth 3YN/A
OCF growth 5YN/A